Your browser doesn't support javascript.
loading
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.
Edelman, Martin J; Lapidus, Rena; Feliciano, Josephine; Styblo, Miroslav; Beumer, Jan H; Liu, Tao; Gobbru, Jogarao.
Affiliation
  • Edelman MJ; University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA. medelman@umm.edu.
  • Lapidus R; University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA.
  • Feliciano J; University of Maryland Greenebaum Cancer Center, 22 S. Greene Street, Baltimore, MD, 21201, USA.
  • Styblo M; Department of Nutrition, University of North Carolina, Chapel Hill, NC, USA.
  • Beumer JH; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Liu T; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.
  • Gobbru J; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Cancer Chemother Pharmacol ; 78(5): 959-967, 2016 Nov.
Article in En | MEDLINE | ID: mdl-27620207
Subject(s)
Key words
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2016 Document type: Article
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2016 Document type: Article